Cargando…
Bimodal Imaging of Tumors via Genetically Engineered Escherichia coli
Although there are emerging innovations of molecular imaging probes to detect and image tumors, most of these molecular dyes and nanoparticles have limitations of low targetability in tumors and fast clearance when administered systemically. In contrast, some bacteria, such as Escherichia coli MG165...
Autores principales: | Zhang, Linlin, Wang, Yuanyuan, Li, Dengjin, Wang, Liang, Li, Zhenzhou, Yan, Fei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501408/ https://www.ncbi.nlm.nih.gov/pubmed/36145552 http://dx.doi.org/10.3390/pharmaceutics14091804 |
Ejemplares similares
-
Correction: Zhang et al. Bimodal Imaging of Tumors via Genetically Engineered Escherichia coli. Pharmaceutics 2022, 14, 1804
por: Zhang, Linlin, et al.
Publicado: (2023) -
Biosynthesis of L‐5‐methyltetrahydrofolate by genetically engineered Escherichia coli
por: Wang, Yubo, et al.
Publicado: (2022) -
Engineering Escherichia coli to improve tryptophan production via genetic manipulation of precursor and cofactor pathways
por: Li, Zhu, et al.
Publicado: (2020) -
Increased Hydrogen Production by Genetic Engineering of Escherichia coli
por: Fan, Zhanmin, et al.
Publicado: (2009) -
US/MR Bimodal Imaging-Guided Bio-Targeting Synergistic Agent for Tumor Therapy
por: Jiang, Fujie, et al.
Publicado: (2022)